EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Testing for SARS-CoV-2: lessons learned and current use cases

Elitza S Theel iD, James E Kirby iD, Nira R Pollock iD

Clinical Microbiology Reviews · 2024

DOI: 10.1128/cmr.00072-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, 2024. Verfasst von Elitza S Theel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Testing. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 289 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and worldwide dissemination of SARS-CoV-2 required both urgent development of new diagnostic tests and expansion of diagnostic testing capacity on an unprecedented scale. The rapid evolution of technologies that allowed testing to move out of traditional laboratories and into point-of-care testing centers and the home transformed the diagnostic landscape. Four years later, with the end of the formal public health emergency but continued global circulation of the virus, it is important to take a fresh look at available SARS-CoV-2 testing technologies and consider how they should be used going forward. This review considers current use case scenarios for SARS-CoV-2 antigen, nucleic acid amplification, and immunologic tests, incorporating the latest evidence for analytical/clinical performance characteristics and advantages/limitations for each test type to inform current debates about how tests should or should not be used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 TestingHumansNucleic Acid Amplification TechniquesAntigens, ViralCOVID-19 Nucleic Acid TestingImmunologic Tests

Stichwörter der Autor:innen

SARS-CoV-2antigendiagnosticmolecularserologytestuse case

Substanzen

Antigens, Viral

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Elitza S Theel, James E Kirby, Nira R Pollock

Zitieren

APA

Theel, E. S., Kirby, J. E., & Pollock, N. R. (2024). Testing for SARS-CoV-2: lessons learned and current use cases. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00072-23

Vancouver

Theel ES, Kirby JE, Pollock NR. Testing for SARS-CoV-2: lessons learned and current use cases. Clinical Microbiology Reviews. 2024. doi:10.1128/cmr.00072-23

BibTeX
@article{Theel2024,
  author = {Theel, Elitza S and Kirby, James E and Pollock, Nira R},
  title = {Testing for SARS-CoV-2: lessons learned and current use cases},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  doi = {10.1128/cmr.00072-23}
}
Kostenlos starten →